Cargando…
Publisher Correction: Plasma p-tau231 and p-tau217 as state markers of amyloid-β pathology in preclinical Alzheimer’s disease
| Autores principales: | , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group US
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9499861/ https://www.ncbi.nlm.nih.gov/pubmed/36100683 http://dx.doi.org/10.1038/s41591-022-02037-1 |
| _version_ | 1784795091472220160 |
|---|---|
| author | Milà-Alomà, Marta Ashton, Nicholas J. Shekari, Mahnaz Salvadó, Gemma Ortiz-Romero, Paula Montoliu-Gaya, Laia Benedet, Andrea L. Karikari, Thomas K. Lantero-Rodriguez, Juan Vanmechelen, Eugeen Day, Theresa A. González-Escalante, Armand Sánchez-Benavides, Gonzalo Minguillon, Carolina Fauria, Karine Molinuevo, José Luis Dage, Jeffrey L. Zetterberg, Henrik Gispert, Juan Domingo Suárez-Calvet, Marc Blennow, Kaj |
| author_facet | Milà-Alomà, Marta Ashton, Nicholas J. Shekari, Mahnaz Salvadó, Gemma Ortiz-Romero, Paula Montoliu-Gaya, Laia Benedet, Andrea L. Karikari, Thomas K. Lantero-Rodriguez, Juan Vanmechelen, Eugeen Day, Theresa A. González-Escalante, Armand Sánchez-Benavides, Gonzalo Minguillon, Carolina Fauria, Karine Molinuevo, José Luis Dage, Jeffrey L. Zetterberg, Henrik Gispert, Juan Domingo Suárez-Calvet, Marc Blennow, Kaj |
| author_sort | Milà-Alomà, Marta |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9499861 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Nature Publishing Group US |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94998612022-09-24 Publisher Correction: Plasma p-tau231 and p-tau217 as state markers of amyloid-β pathology in preclinical Alzheimer’s disease Milà-Alomà, Marta Ashton, Nicholas J. Shekari, Mahnaz Salvadó, Gemma Ortiz-Romero, Paula Montoliu-Gaya, Laia Benedet, Andrea L. Karikari, Thomas K. Lantero-Rodriguez, Juan Vanmechelen, Eugeen Day, Theresa A. González-Escalante, Armand Sánchez-Benavides, Gonzalo Minguillon, Carolina Fauria, Karine Molinuevo, José Luis Dage, Jeffrey L. Zetterberg, Henrik Gispert, Juan Domingo Suárez-Calvet, Marc Blennow, Kaj Nat Med Publisher Correction Nature Publishing Group US 2022-09-13 2022 /pmc/articles/PMC9499861/ /pubmed/36100683 http://dx.doi.org/10.1038/s41591-022-02037-1 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Publisher Correction Milà-Alomà, Marta Ashton, Nicholas J. Shekari, Mahnaz Salvadó, Gemma Ortiz-Romero, Paula Montoliu-Gaya, Laia Benedet, Andrea L. Karikari, Thomas K. Lantero-Rodriguez, Juan Vanmechelen, Eugeen Day, Theresa A. González-Escalante, Armand Sánchez-Benavides, Gonzalo Minguillon, Carolina Fauria, Karine Molinuevo, José Luis Dage, Jeffrey L. Zetterberg, Henrik Gispert, Juan Domingo Suárez-Calvet, Marc Blennow, Kaj Publisher Correction: Plasma p-tau231 and p-tau217 as state markers of amyloid-β pathology in preclinical Alzheimer’s disease |
| title | Publisher Correction: Plasma p-tau231 and p-tau217 as state markers of amyloid-β pathology in preclinical Alzheimer’s disease |
| title_full | Publisher Correction: Plasma p-tau231 and p-tau217 as state markers of amyloid-β pathology in preclinical Alzheimer’s disease |
| title_fullStr | Publisher Correction: Plasma p-tau231 and p-tau217 as state markers of amyloid-β pathology in preclinical Alzheimer’s disease |
| title_full_unstemmed | Publisher Correction: Plasma p-tau231 and p-tau217 as state markers of amyloid-β pathology in preclinical Alzheimer’s disease |
| title_short | Publisher Correction: Plasma p-tau231 and p-tau217 as state markers of amyloid-β pathology in preclinical Alzheimer’s disease |
| title_sort | publisher correction: plasma p-tau231 and p-tau217 as state markers of amyloid-β pathology in preclinical alzheimer’s disease |
| topic | Publisher Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9499861/ https://www.ncbi.nlm.nih.gov/pubmed/36100683 http://dx.doi.org/10.1038/s41591-022-02037-1 |
| work_keys_str_mv | AT milaalomamarta publishercorrectionplasmaptau231andptau217asstatemarkersofamyloidbpathologyinpreclinicalalzheimersdisease AT ashtonnicholasj publishercorrectionplasmaptau231andptau217asstatemarkersofamyloidbpathologyinpreclinicalalzheimersdisease AT shekarimahnaz publishercorrectionplasmaptau231andptau217asstatemarkersofamyloidbpathologyinpreclinicalalzheimersdisease AT salvadogemma publishercorrectionplasmaptau231andptau217asstatemarkersofamyloidbpathologyinpreclinicalalzheimersdisease AT ortizromeropaula publishercorrectionplasmaptau231andptau217asstatemarkersofamyloidbpathologyinpreclinicalalzheimersdisease AT montoliugayalaia publishercorrectionplasmaptau231andptau217asstatemarkersofamyloidbpathologyinpreclinicalalzheimersdisease AT benedetandreal publishercorrectionplasmaptau231andptau217asstatemarkersofamyloidbpathologyinpreclinicalalzheimersdisease AT karikarithomask publishercorrectionplasmaptau231andptau217asstatemarkersofamyloidbpathologyinpreclinicalalzheimersdisease AT lanterorodriguezjuan publishercorrectionplasmaptau231andptau217asstatemarkersofamyloidbpathologyinpreclinicalalzheimersdisease AT vanmecheleneugeen publishercorrectionplasmaptau231andptau217asstatemarkersofamyloidbpathologyinpreclinicalalzheimersdisease AT daytheresaa publishercorrectionplasmaptau231andptau217asstatemarkersofamyloidbpathologyinpreclinicalalzheimersdisease AT gonzalezescalantearmand publishercorrectionplasmaptau231andptau217asstatemarkersofamyloidbpathologyinpreclinicalalzheimersdisease AT sanchezbenavidesgonzalo publishercorrectionplasmaptau231andptau217asstatemarkersofamyloidbpathologyinpreclinicalalzheimersdisease AT minguilloncarolina publishercorrectionplasmaptau231andptau217asstatemarkersofamyloidbpathologyinpreclinicalalzheimersdisease AT fauriakarine publishercorrectionplasmaptau231andptau217asstatemarkersofamyloidbpathologyinpreclinicalalzheimersdisease AT molinuevojoseluis publishercorrectionplasmaptau231andptau217asstatemarkersofamyloidbpathologyinpreclinicalalzheimersdisease AT dagejeffreyl publishercorrectionplasmaptau231andptau217asstatemarkersofamyloidbpathologyinpreclinicalalzheimersdisease AT zetterberghenrik publishercorrectionplasmaptau231andptau217asstatemarkersofamyloidbpathologyinpreclinicalalzheimersdisease AT gispertjuandomingo publishercorrectionplasmaptau231andptau217asstatemarkersofamyloidbpathologyinpreclinicalalzheimersdisease AT suarezcalvetmarc publishercorrectionplasmaptau231andptau217asstatemarkersofamyloidbpathologyinpreclinicalalzheimersdisease AT blennowkaj publishercorrectionplasmaptau231andptau217asstatemarkersofamyloidbpathologyinpreclinicalalzheimersdisease |